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Abstract
Background—Influenza vaccination coverage in the United States remains below national 
targets and racial/ethnic differences persist.
Objectives—To gain insights into potential strategies for improving influenza vaccination by 
examining reasons given for not receiving an influenza vaccination during the 2011–12 influenza 
season.
Methods—Data from the National Flu Survey were analyzed for the 2011–12 influenza season.
Tests of association between reasons for non-vaccination and demographic variables were 
conducted using Wald chi-square tests. Multivariable logistic regression analyses were used to 
determine variables independently associated with each reason for non-vaccination.
Results—For adults and children, there were no racial/ethnic differences in the overall most 
frequent reason for non-vaccination: “unlikely to get very sick from the flu”. Regarding adults, 
there were racial/ethnic differences in seven of the twelve reasons for non-vaccination in bivariate 
analyses, but only three remained significant in the multivariable models. Most notable of these 
was that blacks (40.9%) were more likely than Hispanics (27.0%), whites (25.2%), and adults of 
other/multiple races (21.2%) to report concerns about getting the flu from the vaccination and 
blacks (39.8%) were more likely than whites (28.4%) and adults of other/multiple races (29.3%) to 
report concerns about side effects from the vaccine. Regarding children, there were racial/ethnic 
differences for three of the reasons for non-vaccination, and these remained significant in the 
multivariable models. The most noteworthy of these was that more black (44.4%) than white 
(24.0%) and other/multiple race (19.0%) parents had concerns about their child getting the flu 
from the vaccination. Other demographic variables (age, gender income, MSA for adults and age 
and income for children) were also associated with reasons for non-vaccination based on the 
multivariable models.
Conclusions—There are racial/ethnic group differences in reasons for not receiving an influenza 
vaccination; recognition of these differences should guide the choice of interventions to increase 
vaccination rates.
☆The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of CDC.
*Corresponding author at: Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop A-19, Atlanta, GA 
30329-4027, United States. afz5@cdc.gov (T.A. Santibanez). 
HHS Public Access
Author manuscript
Vaccine. Author manuscript; available in PMC 2018 January 03.
Published in final edited form as:
Vaccine. 2016 May 23; 34(24): 2671–2678. doi:10.1016/j.vaccine.2016.04.039.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
Adult; Child; Influenza; Human; United States; Vaccination
1. Introduction
Since 2010, the Advisory Committee for Immunization Practices has recommended 
influenza vaccination for all people ≥6 months of age [1]. Yet, during the 2014–15 influenza 
season, only 43.6% of adults and 59.3% of children were vaccinated [2]. These rates remain 
below the national Healthy People 2020 target of 70% influenza vaccination coverage for 
adults and children [3]. Furthermore, racial/ethnic differences in influenza vaccination 
coverage have been persistent, with coverage being even lower for some racial/ethnic groups 
[4,5].
Many evidence-based strategies have been promoted for increasing influenza vaccination 
coverage, including but not limited to standing orders, provider reminders and 
recommendations, expanding access to vaccination services by reducing cost, and having 
vaccinations available at schools and pharmacies and other non-medical sites [6,7]. These 
strategies do not take into account specific patient attitudes; however, these strategies have 
been shown to work regardless of patient attitude [8]. Yet attitudes play a role in accepting 
vaccination as evidenced by a study of pregnant women which found the percentage 
vaccinated among women recommended and offered vaccine by their physician was 77.2% 
for those with a positive attitude about vaccine efficacy compared with 15.4% for those with 
a negative attitude; the percentages vaccinated were 79.2% for those with a positive and 
26.1% for those with a negative attitude about vaccine safety [9]. An exploration of reasons 
for non-vaccination, by quantifying the most common reasons given for non-vaccination, 
could be useful to healthcare providers and immunization programs so that they are better 
prepared to address the concerns of patients. This could aid efforts to increase vaccination 
rates and decrease disparities in influenza vaccination. The objective of this study was to 
examine the reasons given for not receiving an influenza vaccination for adults and for 
children overall and by racial/ethnic group.
2. Methods
2.1. Survey description
Data from the National Flu Survey (NFS) were analyzed. The NFS was designed to provide 
rapid national estimates of influenza vaccination coverage and knowledge, attitudes, and 
practices during the influenza season and again at the end of the season. The NFS was 
sponsored by CDC and conducted by NORC at the University of Chicago in November 
2010, March and November 2011, and lastly in March 2012 [10]. This study used data from 
the March 2012 NFS which included interviews conducted during March 1–29, 2012. The 
sample for the NFS was a list-assisted random digit-dial sample of both landline and cellular 
telephones. The interviews were conducted in English or Spanish with language line 
interpretation services used to conduct the survey in other languages as needed. Cellular 
telephone respondents were screened into the survey if they were a “cell telephone only” 
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household (i.e., they reported that they do not maintain a landline telephone in their 
household) or a “cell telephone mainly” household (i.e., they maintain a landline but are 
unlikely to answer it if it rings while an adult is at home), and they were ≥18 years. For the 
landline sample, the youngest male ≥18 years currently at home was selected to be 
interviewed; if there were no males at home, the youngest female ≥18 years was selected 
[11]. For the cell telephone sample, the adult who answered the cell phone was selected to 
be interviewed. For interviews pertaining to children, the adult respondent was asked the 
ages of all children in the household younger than 18 years and one child was randomly 
selected. Then the interviewer stated that for the next section they needed to talk to the 
parent or guardian living in the household who knows about the health and health care of the 
selected child. If the respondent was the parent/guardian they continued with the survey; if 
they were not, the parent/guardian came to the phone or the interview was rescheduled for 
another time with the parent/guardian. Hereafter in this paper the parent/guardian is referred 
to as the parent.
The March 2012 survey questionnaire included questions about receipt of influenza 
vaccination, reasons for non-vaccination, and demographic questions. To assess influenza 
vaccination status, the respondents were asked: “Since July 1st, 2011, have you had a flu 
vaccination? It could have been a shot or a spray, drop, or mist in the nose.” For those 
responding that they were unvaccinated, the following questions were asked: “There are 
many reasons why people do not get flu vaccinations. I am going to read you a list of 
reasons why people may not get a flu vaccination. Please tell me if each is a reason why you 
did not get a flu vaccination this flu season. You did not get the flu vaccination this year 
because…” The list included the following with the respondent reporting if it was a reason 
of theirs after each was read: you are allergic to the vaccine; you don’t like needles and 
shots; you never get the flu; you are unlikely to get very sick from the flu; you did not have 
time to get the vaccination; you were not in a high risk or priority group; you were 
concerned about getting the flu from the vaccination; you were concerned about side effects 
from the vaccination other than getting the flu from the vaccine; you have an ongoing health 
condition that prevents you from getting the vaccination; you believe the flu vaccines do not 
work very well; you do not trust what the government says about the flu; the vaccine costs 
too much; you did not want the vaccination for some other reason. For reasons why the child 
did not receive a vaccination, the parent was asked the reasons for not having the child 
vaccinated in the same format as previously described. Information on the following 
demographic characteristics were included in this study: adult’s and child’s age, race/
ethnicity, and sex, adult’s education, income/poverty level, and Metropolitan Statistical Area 
(MSA) category. The income/poverty level variable was defined based on total family 
income in the past calendar year, and the U.S. Census poverty thresholds for that year 
specified for the applicable family size and number of children <18 years.
The Council of American Survey Research Organizations (CASRO) response rate for the 
NFS was 31% for landlines and 18% for cell phones [12]. The CASRO response rate is the 
product of the percentage of telephone lines identified as residential or nonresidential 
(landline 76.2%, cell 49.0%), the percentage of known households with a completed 
screening interview (landline 96.6%, cell 72.6%), and the percentage of eligible respondents 
who complete the interview (landline 42.6%, cell 51.5%). A total of 15,630 households 
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completed interviews (12,503 landline, 3127 cell); of these, 12,082 households had an 
interview regarding an adult only and 3548 households had an interview regarding both an 
adult and a child. Thus, there were completed interviews for 19,178 persons in the sample; 
of these, 19,017 had a non-missing influenza vaccination status (15,583 regarding adults, 
3434 regarding children). Among the 15,583 interviews regarding adults, 45.5% received 
influenza vaccination in the 2011–12 season; the sample size of unvaccinated adults 
included in this study was 7398. Among the 3434 interviews regarding children, 55.5% of 
children were vaccinated; the sample size of unvaccinated children included was 1505. Of 
these 1505, there were 131 or 8.3%, in which the initial adult respondent was not the parent 
and the interview switched to the parent for the child questions. This left 1374 (91.7%) of 
the 1505 unvaccinated children in which the initial adult respondent was the parent of the 
child. Of these 1374 unvaccinated children, 316 had vaccinated parents leaving 1056 
unvaccinated child/parent pairs for which to conduct a sub-analysis to examine agreement 
between reasons given for non-vaccination by parents for themselves versus their children.
2.2. Statistical methods
Tests of association between reasons for non-vaccination and demographic variables were 
conducted using Wald chi-square tests followed by post-hoc pair-wise comparison t-tests. 
Multivariable logistic regression analyses were used to determine variables independently 
associated with each reason for non-vaccination. Adjusted prevalence ratios (APR) based on 
predicted marginals from the logistic regression models were computed [13]. In the sub-
analysis, agreement between reasons for non-vaccination given by parents for themselves 
versus for their children was evaluated using both the proportion of agreement and the 
unweighted kappa statistic, which adjusts for any agreement by chance [14]. Kappa values 
<0.40 show poor agreement, values between 0.40 and 0.75 show fair to good agreement, and 
values >0.75 show excellent agreement [14]. A two-sided significance level of 0.05 was 
adopted for all statistical tests. Reported percentages and corresponding 95% confidence 
intervals (95% CI) were weighted while sample sizes were unweighted. All analyses were 
weighted to population totals and to adjust for households having multiple telephone lines, 
unit non-response, and non-coverage of non-telephone households. Analyses were 
performed using SAS, release 9.3 (SAS Inc., Cary, NC, USA) and SUDAAN, release 11.0.0 
(Research Triangle Institute, Research Triangle Park, NC, USA).
3. Results
Table 1 shows the sample characteristics of the unvaccinated adults included in this study 
with regard to age, race/ethnicity, sex, poverty status, education, and MSA. Approximately 
one-fifth of respondents (17.2%) had only one reason for non-vaccination, with many 
respondents choosing two to four reasons for non-vaccination (Table 1).
The overall percentages of unvaccinated adults indicating each reason for not receiving an 
influenza vaccination during the 2011–12 season are included in Fig. 1. The most common 
were: “unlikely to get very sick from the flu” (52.3%); “never get the flu” (41.8%); “not in a 
high risk or priority group” (34.9%); and “concerned about side effects from the vaccination 
other than getting the flu from the vaccine” (30.9%). Seven of the reasons for non-
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vaccination differed by racial/ethnic group based upon the bivariate analyses; two are 
highlighted here (Table 2). Blacks (40.9%) were more likely than Hispanics (27.0%), whites 
(25.2%), and other/multiple race adults (21.2%) to report concerns about getting the flu from 
the vaccination. Blacks (39.8%) were more likely than whites (28.4%) and other/multiple 
race adults (29.3%) to report concerns about side effects from the vaccine. Additional 
differences are noted in Table 2.
The overall percentage of unvaccinated children whose parents indicated reasons for not 
getting their child the influenza vaccine are included in Fig. 1. The most common were: 
“unlikely to get very sick from the flu” (42.3%); “not in a high risk or priority group” 
(35.8%); “concerned about side effects from the vaccination other than getting the flu from 
the vaccine” (34.7%); and “never get the flu” (34.3%). Among parents, more blacks (44.4%) 
than whites (24.0%) and parents of other/multiple race children (19.0%) had concerns about 
their child getting the flu from the vaccination (Table 2). More Hispanics (16.9%) than 
whites (2.6%) and parents of other/multiple race children (1.1%) reported the child having 
an ongoing health condition as the reason for non-vaccination. More whites (39.4%) than 
blacks (22.1%) reported their child not being in a high risk group as a reason for non-
vaccination. There were no other statistically significant racial/ethnic differences other than 
those described above (Table 2).
Based on the twelve multivariable logistic regression models for adults, many of the 
demographic variables were associated with reasons for non-vaccination (Table 3). Adults in 
the younger age groups were less likely to give the reasons of “allergic to the vaccine”, 
“have an ongoing health condition”, “never get the flu”, or “don’t trust government/doctors” 
compared to adults 65 years and older. Conversely these younger age groups were more 
likely than adults 65 years and older to give the reason “unlikely to get very sick from the 
flu”, “not in a high risk group”, and “the vaccine costs too much”. Adult females were more 
likely than males to give the reasons “concerns about getting the flu from the vaccination”, 
“concerns about side effects from the vaccine”, and “have an ongoing health condition”, but 
were less likely than males to give the reasons “never get the flu” and “unlikely to get very 
sick from the flu”. Black adults were more likely than white adults to give the reasons 
“concerns about getting the flu from the vaccination” and “concerns about side effects from 
the vaccine”, while blacks and Hispanic adults were less likely than whites to give the reason 
“not in a high risk group”. Adults with lower income were more likely than those in the 
highest income group to give the reasons: “don’t like needles shots”, “concerns about getting 
the flu from the vaccine”, concerns about side effects from the vaccine”, “have an ongoing 
health condition”, “don’t’ trust government/doctors”, and “the vaccine costs too much”. 
They were less likely than those in the highest income group to give the reason “not in a 
high risk group”. Adults living in an MSA were more likely than those in non-MSA areas to 
give the reason “have an ongoing health condition”.
Based on the twelve multivariable logistic regression models for parents of children, various 
demographic variables were associated with each reason for non-vaccination of children 
(Table 4). Compared to parents of children in younger age groups, parents of children in 
older age groups were less likely to give the reason “concern about side effects from the 
vaccine” and more likely to give the reasons of “never get the flu” and “unlikely to get very 
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sick from the flu”. Compared to parents of white children, parents of Hispanic children were 
less likely to give the reason “don’t like needles/shots” while more likely to give the reason 
“have an ongoing health condition.” Parents of black children were more likely than those of 
white children to give the reason “concerns about getting the flu from the vaccination” but 
less likely to give the reasons “not in a high risk group”. Parents of children with lower 
income were more likely than those in the highest income group to give the reasons: “don’t 
like needles/shots”, “concerns about side effects from the vaccine”, “have an ongoing health 
condition”, and “the vaccine costs too much”. Sex and MSA were not associated with any of 
the reasons based on the multivariable models.
In the analyses of the subset of unvaccinated parent-child pairs, the observed proportion of 
agreement between the reasons parents gave for not being vaccinated themselves and for not 
having their child vaccinated was >75% for ten of the twelve reasons (Table 5). When 
examining the kappa statistic however there was fair to good agreement for only half of the 
reasons.
4. Discussion
This study found that the most common reasons given for not receiving an influenza 
vaccination during the 2011–12 influenza season were related to not perceiving themselves 
or their child at risk for influenza or not being at risk for getting very ill if they do get the 
disease. Concerns about side effects of the influenza vaccine were generally the next most 
common reasons given. Some previous studies examined reasons for non-vaccination but 
focused only on older adults and did not test for racial/ethnic group differences. In these 
studies the most common reasons were related to not perceiving themselves at risk for 
influenza and concerns about side effects of the influenza vaccine, similar to what our study 
found for all adults and parents [15–17]. Health professionals should take what opportunities 
they have available in their interactions with patients to provide objective information about 
the risks of influenza, the benefits of influenza vaccination, and address concerns that 
parents have. One resource includes the educational patient brochures, posters, and flyers 
available at http://www.cdc.gov/flu/freeresources/print-general.htm
This study found some similarities and differences between the racial/ethnic groups in 
reported reasons for not receiving an influenza vaccination. For example, there were no 
racial/ethnic differences in the overall most frequently given reason for non-vaccination: 
“unlikely to get very sick from the flu”. Among the more striking differences was that 
“concerns about getting the flu from the vaccination” was much more commonly reported as 
a reason for non-vaccination by black adults (41%) and by parents of black children (44%) 
compared to the other racial/ethnic groups (30% or less). This was the most frequently 
reported reason for non-vaccination given by parents of black children, while for all other 
racial/ethnic groups “unlikely to get very sick from the flu” was the most frequently given 
reason. This on-going misconception appears to be more prevalent in black communities 
than other communities and may be a contributing factor to the persistent racial/ethnic 
differences in influenza vaccination coverage. Research has shown that the mere 
presentation of facts and statistics in an attempt to persuade people to change their belief 
may cause them to become more entrenched in the belief [18]. Creative approaches will be 
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needed to dispel this misconception among blacks, as well as among other racial/ethnic 
groups. Because of the finding that reasons for non-vaccination given by parents for 
themselves do not highly correspond to reasons they give for not having their child 
vaccinated, providers should not assume the reasons are the same when talking to parents 
about their vaccination concerns.
The study is subject to at least four limitations. First, vaccination status was based upon self 
or parent report and was not verified with medical records [19–21]. Second, the response 
rate was low however some survey methodologist report that response rates lack validity as a 
measure for survey bias [22]. Third, the accurate measure of reasons for non-vaccination is 
complicated because the reasons can vary over time for the same person and by the way the 
question is asked during a survey; the questions are asked at the time of the interview which 
is months after the decision was made. Fourth, the profile of reasons for non-vaccination for 
the 2011–12 season may not apply to the current or future seasons due to variability in the 
unique circumstances of each influenza season such as reports of early influenza deaths 
among children or a mismatch of the strains in the vaccine and the circulating virus.
In conclusion, the most common reasons for non-vaccination were related to not perceiving 
the risks of influenza and concerns about side effects of the influenza vaccine and there were 
racial/ethnic differences in reasons. Knowledge of these findings can guide the choice of 
interventions to decrease racial/ethnic differences in influenza vaccination rates. Healthcare 
providers, as well as immunization programs and their partners, should be made aware of the 
many reasons for non-vaccination and utilize strategies to help address these barriers.
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Fig. 1. 
Percentage of unvaccinated adults reporting each reason for non-vaccination and parents 
reporting reasons for non-vaccination for their children, 2011–12 influenza season, National 
Flu Survey (based on interviews conducted March 1–29, 2012), United States.
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Santibanez and Kennedy Page 10
Table 1
Sample characteristics of unvaccinated adults and children, 2011–12 influenza season, National Flu Survey*, 
United States.
Demographic characteristic Adults Children
n % ± 95% CI† n % ± 95% CI
Overall 7398 1505
Age group – – – –
  ≤4 years 3728 – 244 19.2 ± 3.4
  5–12 years 2279 – 616 42.4 ± 4.3
  13–17 years 1391 – 645 38.4 ± 4.1
  18–49 years 68.8 ± 1.7 – –
  50–64 years 22.0 ± 1.5 – –
  65+ years 9.2 ± 0.9 – –
Race/ethnicity – – – –
  Hispanic 913 15.7 ± 1.7 248 17.2 ± 3.2
  Black only, non-Hispanic 941 14.1 ± 1.6 198 13.3 ± 2.9
  White only, non-Hispanic 4936 63.0 ± 2.1 886 63.1 ± 4.0
  Other or multiple race, non-Hispanic 608 7.2 ± 1.1 173 6.4 ± 1.6
Sex – – – –
  Male 3680 51.3 ± 2.1 764 49.8 ± 4.3
  Female 3718 48.7 ± 2.1 741 50.2 ± 4.3
Poverty status‡ – – – –
  Above poverty, >$75,000/year 2162 28.0 ± 1.9 643 37.9 ± 4.1
  Above poverty, ≤$75,000/year 2064 29.6 ± 2.0 411 29.8 ± 4.1
  At or below poverty 954 16.3 ± 1.7 191 15.7 ± 3.2
  Not reported 2218 26.1 ± 1.8 260 16.6 ± 3.0
Education – – – –
  <12 years 611 9.5 ± 1.3 – –
  12 years 1331 21.4 ± 1.8 – –
  Some college 1878 29.2 ± 2.0 – –
  College graduate 2763 32.1 ± 1.9 – –
  Not reported 815 7.9 ± 1.0 – –
MSAa – – – –
  MSA, principle city 3280 39.6 ± 2.1 590 33.2 ± 3.8
  MSA, not principle city 3116 43.8 ± 2.1 733 49.3 ± 4.3
  Non-MSA 1002 16.6 ± 1.6 182 17.5 ± 3.5
Number of reasons given
  0 276 2.6 ± 0.6 88 5.7 ± 1.9
  1 1323 17.2 ± 1.5 312 21.4 ± 3.5
  2 1705 22.7 ± 1.7 302 19.5 ± 3.3
  3 1561 23.0 ± 2.0 316 23.1 ± 3.6
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Demographic characteristic Adults Children
n % ± 95% CI† n % ± 95% CI
  4 1118 15.7 ± 1.5 216 12.6 ± 2.8
  5 687 8.8 ± 1.2 113 7.5 ± 2.4
  6 407 5.8 ± 1.0 94 5.1 ± 1.6
  7 184 2.5 ± 0.7 35 3.4 ± 2.1
  8–12 137 1.7 ± 0.5 29 1.8 ± 1.1
*Sample includes interviews conducted March 1–29, 2012.
†Weighted percentage and 95% Confidence Interval half-width.
‡
The income/poverty level variable was defined based on total family income in the past calendar year, and the U.S. Census poverty thresholds for 
that year specified for the applicable family size and number of children <18 years. Poverty thresholds are available at http://www.census.gov/
hhes/www/poverty/data/threshld/index.html.
a
MSA = Metropolitan statistical area.
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